and
resistance to therapy. Prostate
cancer patients often have long time periods between curative intent surgery
Parfenov, E,
Parfenova, L,
Mukaeva, V,
Farrakhov, R,
Stotskiy, A,
Raab, A,
Danilko, K,
Rameshbabu, N,
Valiev, R (2020) ) tripeptide sequence anchored to the surface with a bisphosphonate linker. In terms of wear
resistanceGareev, I,
Beylerli, O,
Wang, CL,
Sokhatskii, A,
Liang, YC,
Xiang, H,
Liu, CY,
Xu, X,
Guang, Y (2022) fluids. Owing to their stability and
resistance to endogenous RNase activity, circulating miRNAs have
Xun, Xu,,
Liang, Yuan,
Gareev, Ilgiz,
Liang, Yanchao,
Liu, Rui,
Wang, Ning,
Yang, Guang (2023) and chemoradiotherapy
resistance, we discussed the feasibility for lncRNAs as therapeutic targets. Finally
Bogdanov, A,
Tsivileva, O,
Voloshina, A,
Lyubina, A,
Amerhanova, S,
Burtceva, E,
Bukharov, S,
Samorodov, A,
Pavlov, V (2022) Staphylococcus aureus and Bacillus cereus higher or at the level of norfloxacin, including methicillin-
resistantMENG, X.,
DUAN, C.,
PANG, H.,
CHEN, Q.,
HAN, B.,
MAGAFUROV, D.A.,
WU, P.,
LI, Z.,
ZHAO, S.,
WANG, R.,
LIN, L.,
JIANG, C.,
CAI, J.,
ZHA, C. (2019) , progression, and
therapeutic
resistance. However, the involvement of DDR alterations in glioma malignancy
Дьяконов, В.А.,
Джемилева, Л.У.,
Джемилев, У.М.,
D'yakonov, V.A.,
Dzhemileva, L.U.,
Dzhemilev, U.M. (2017) of multidrug
resistance. The way of overcoming these shortcomings is to create anticancer drugs with improved
MENG, X.,
DUAN, C.,
PANG, H.,
CHEN, Q.,
HAN, B.,
MAGAFUROV, D.A.,
WU, P.,
LI, Z.,
ZHAO, S.,
WANG, R.,
LIN, L.,
JIANG, C.,
CAI, J.,
ZHA, C. (2019) , progression, and therapeutic
resistance. However, the involvement of DDR alterations in glioma malignancy
Tinkov, Alexey A.,
Gatiatulina, Eugenia R.,
Popova, Elizaveta V.,
Polyakova, Valentina S.,
Skalnaya, Anastasia A.,
Agletdinov, Eduard F.,
Nikonorov, Alexandr A.,
Skalny, Anatoly V. (2017) insulin
resistance, adiponectin deficiency, and proatherogenic state. Hypothetically, trace element